to reach at the end. right, ok. by digitally mapping the position of my face and features, it's able to precisely trace my eyes' micro movements, without the need to restrain my head in a fixed position. you're going to follow the dot to the other direction. the test is designed to be quick and painless, and accessible for people, even in remote parts of the world. but the company is some way from fda approval. it's looking for partners to validate its technology. how do you know that this, you know... that this works? that this works! yeah, so, there are over 750 papers published in the last 20—25 years, showing that there are deep correlations between ocular markers and the progression of these diseases. we have four trials that are ongoing now. all results we have coming in, specifically from parkinson's and als, are kind of mind—boggling. not only are we able to differentiate between healthy and sick patients but actually